About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Gene Therapy and Regulation
›
top-articles
Gene Therapy and Regulation
0.3
(top 100%)
impact factor
69
(top 100%)
papers
320
(top 50%)
citations
9
(top 50%)
h
-index
0.3
(top 100%)
impact factor
81
all documents
326
doc citations
16
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
3D CELL BIOPRINTING FOR REGENERATIVE MEDICINE RESEARCH AND THERAPIES
Gene Therapy and Regulation
2012
55
2
DROP-ON-DEMAND INKJET BIOPRINTING: A PRIMER
Gene Therapy and Regulation
2011
49
3
Polycation/DNA complexes for in vivo gene delivery
Gene Therapy and Regulation
2000
23
4
A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION
Gene Therapy and Regulation
2010
14
5
Spliceosome-mediated RNA trans-splicing in gene therapy and genomics
Gene Therapy and Regulation
2000
13
6
Dual-regulated gene expression in mammalian cells, a novel approach to gene therapy
Gene Therapy and Regulation
2001
12
7
Reconstituted fusion liposomes for gene transfer in vitro and in vivo
Gene Therapy and Regulation
2000
10
8
Antisense derivatives of U7 and other small nuclear RNAs as tools to modify pre-mRNA splicing patterns
Gene Therapy and Regulation
2004
10
9
Improvement of RNA-DNA oligonucleotide design by using mammalian nuclear extracts
Gene Therapy and Regulation
2000
9
10
Globin gene transfer: a paradigm for transgene regulation and vector safety
Gene Therapy and Regulation
2003
9
11
Alphavirus vectors: from protein production to gene therapy
Gene Therapy and Regulation
2000
8
12
CLINICAL DEVELOPMENT OF A THIRD-GENERATION ONCOLYTIC HSV-1 (G47Δ) FOR MALIGNANT GLIOMA
Gene Therapy and Regulation
2010
8
13
HIGH-THROUGHPUT, MASSIVELY PARALLEL DNA SEQUENCING TECHNOLOGY FOR THE ERA OF PERSONALIZED MEDICINE
Gene Therapy and Regulation
2007
7
14
Intracoronary gene transfer of fibroblast growth factor in experimental and clinical myocardial ischemia
Gene Therapy and Regulation
2001
6
15
Phage φC31 integrase-mediated site-specific integration for gene therapy
Gene Therapy and Regulation
2003
6
16
Xenomitochondrial embryonic stem cells and mice: modeling human mitochondrial biology and disease
Gene Therapy and Regulation
2004
6
17
EDITORIAL: "AUTOLOGOUS STEM CELL GENE THERAPY: TOWARD A UNIVERSAL PLATFORM FOR PERSONALIZED THERAPY"
Gene Therapy and Regulation
2007
5
18
TRANSLATIONAL PERSPECTIVES — TRANSIENT EPIGENETIC GENE THERAPY: HAZARD-FREE CELL REPROGRAMMING APPROACH AND RISING ARM OF A UNIVERSAL STEM CELL GENE THERAPY PLATFORM
Gene Therapy and Regulation
2009
5
19
Antiangiogenic gene therapy
Gene Therapy and Regulation
2000
4
20
Spontaneous heart regeneration in adult MRL mice after cryoinjury
Gene Therapy and Regulation
2001
4
21
Positron-emission tomography monitoring of anti-glioblastoma HSV-1-
tk
gene therapy
Gene Therapy and Regulation
2003
4
22
Liver-selective nucleic acid targeting using the asialoglycoprotein receptor
Gene Therapy and Regulation
2000
3
23
Derivation and properties of human embryonic stem cell-derived cardiomyocytes
Gene Therapy and Regulation
2001
3
24
Hepatocyte growth factor (HGF) angiogenic gene therapy: promises for cardiovascular diseases
Gene Therapy and Regulation
2001
3
25
Engineered Cys
2
His
2
zinc finger DNA-binding domains
Gene Therapy and Regulation
2004
3
26
Cancer gene therapy — current status in the clinics
Gene Therapy and Regulation
2004
3
27
ENGINEERING HOMING ENDONUCLEASES TO MODIFY COMPLEX GENOMES
Gene Therapy and Regulation
2007
3
28
GENE THERAPY FOR PARKINSON'S DISEASE: STRATEGIES FOR THE LOCAL PRODUCTION OF DOPAMINE
Gene Therapy and Regulation
2010
3
29
NUCLEAR REPROGRAMMING AND THE CURRENT CHALLENGES IN ADVANCING PERSONALIZED PLURIPOTENT STEM CELL-BASED THERAPIES
Gene Therapy and Regulation
2012
3
30
RNA and gene repair/alteration: from inherited diseases to acquired disorders and tantalizing applications for non-disease conditions
Gene Therapy and Regulation
2000
2
31
Adeno-associated viral vectors and successful gene therapy, the gap is closing
Gene Therapy and Regulation
2000
2
32
Adult and embryonic-like stem cells: toward a major gene therapy breakthrough relying on autologous multipotent stem cells
Gene Therapy and Regulation
2001
2
33
Stem cell gene therapy: breakthrough culminating in combination of
ex vivo
protocols with transient topical gene therapy
Gene Therapy and Regulation
2003
2
34
Non-viral methods of gene transfer to airway epithelium
Gene Therapy and Regulation
2003
2
35
Editorial — Zinc finger nuclease-boosted gene targeting: toward clinical gene repair/alteration and custom site-specific integrative gene therapy
Gene Therapy and Regulation
2004
2
36
Transmitochondrial stem cells: from mouse models of mtDNA diseases to autologous cybrid stem cell gene therapy
Gene Therapy and Regulation
2004
2
37
Method — A nonviral gene transfer method for transfecting multipotent adult progenitor cells (MAPC)
Gene Therapy and Regulation
2004
2
38
NEURAL STEM CELLS AND ARMED DERIVATIVES: FATE AND THERAPEUTIC POTENTIAL IN THE BRAIN
Gene Therapy and Regulation
2007
2
39
RNA-DIRECTED CONTROL OF TRANSCRIPTION IN HUMAN CELLS: SPECIFICALLY TURNING GENES ON OR OFF
Gene Therapy and Regulation
2009
2
40
SMART ADENOVIRUS NANOCOMPLEXES FOR SYSTEMIC DELIVERY
Gene Therapy and Regulation
2010
2
41
MLV-derived retroviral pseudotype vectors
Gene Therapy and Regulation
2000
1
42
Targeted inhibition of type I procollagen synthesis by antisense DNA oligonucleotides
Gene Therapy and Regulation
2000
1
43
From therapeutic angiogenesis to myocardium regeneration
Gene Therapy and Regulation
2001
1
44
Clinical trials of myocardial VEGF gene transfer
Gene Therapy and Regulation
2001
1
45
The pros and cons of using the mechanism of AAV site-specific recombination in gene delivery
Gene Therapy and Regulation
2003
1
46
Alternative capsid strategies for targeting recombinant AAV gene therapy
Gene Therapy and Regulation
2003
1
47
Herpes simplex virus type 1/adeno-associated virus hybrid vectors
Gene Therapy and Regulation
2003
1
48
Method — Intra-bone marrow transplantation of hematopoietic stem cells in non-human primates: long-term engraftment without conditioning
Gene Therapy and Regulation
2004
1
49
Small RNA-mediated chromatin modification and transcriptional gene silencing
Gene Therapy and Regulation
2004
1
50
CELL-FREE SELECTION OF DNA-BINDING PROTEINS FOR FUTURE GENE THERAPY APPLICATIONS
Gene Therapy and Regulation
2007
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.